CUTANEOUS T-CELL LYMPHOMA, UNSPECIFIED

Clinical trials for CUTANEOUS T-CELL LYMPHOMA, UNSPECIFIED explained in plain language.

Never miss a new study

Get alerted when new CUTANEOUS T-CELL LYMPHOMA, UNSPECIFIED trials appear

Sign up with your email to follow new studies for CUTANEOUS T-CELL LYMPHOMA, UNSPECIFIED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New IV drug trial offers hope for patients with aggressive lymphoma

Disease control Recruiting now

This is an early-stage study testing a new intravenous drug called ST-001 for people with T-cell lymphoma that has come back or not responded to prior treatments. The main goals are to find the highest safe dose and understand how the drug works in the body. It is for adults whos…

Matched conditions: CUTANEOUS T-CELL LYMPHOMA, UNSPECIFIED

Phase: PHASE1 • Sponsor: SciTech Development, Inc. • Aim: Disease control

Last updated Mar 19, 2026 14:56 UTC

CUTANEOUS T-CELL LYMPHOMA, UNSPECIFIED

Get alerted when new CUTANEOUS T-CELL LYMPHOMA, UNSPECIFIED trials appear

New IV drug trial offers hope for patients with aggressive lymphoma